Telemedicine for stroke care in Chinese hospitals
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests if connecting smaller hospitals with stroke experts through telemedicine improves treatment for people having an acute ischemic stroke. It may help you get faster, better care if you live in a less populated area.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with an acute ischemic stroke (a type of stroke caused by a blood clot).
- A CT or MRI scan showed no bleeding in your brain.
- Your stroke symptoms started less than 4.5 hours ago.
- You were able to do your daily activities independently before your stroke (mRS score 0 or 1).
- You go to a basic-level hospital (not a large specialized center) in China.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This trial tests a special emergency stroke unit that uses advanced brain imaging (NeuAngio-CT) to quickly evaluate and treat people having an acute ischemic stroke. It aims to improve outcomes by speeding up care and guiding treatment decisions.
This trial tests whether a traditional Chinese medicine (Angong Niuhuang pill) made from different sources of a natural ingredient can help people who recently had a moderate stroke caused by a blood clot. It aims to see if the pill can improve recovery.
This study is collecting information from people in Southwest China who have had a stroke caused by a blocked large or medium artery. The goal is to learn more about these strokes and how to treat them better.
This study is collecting information on stroke patients who received the clot-dissolving drug tenecteplase. It aims to see how well the drug works and how safe it is in everyday hospital care in China.
This study tests whether using telemedicine (remote health technology) combined with care at a local village clinic can better prevent strokes and manage stroke risk in older adults living in rural areas. Participants will receive ongoing health monitoring and support tailored to their stroke risk factors.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.